TriSalus Life Sciences Inc. (TLSI) Live Share Price, Invest From India

TriSalus Life Sciences Inc. Stock Performance

as on June 24, 2026 at 4:12 am IST

Day's Low
Day's High
$4.12
Day's Price Range
$4.37
$4.23
2.60%
Downside
3.31%
Upside
52 Week's Low
52 Week's High
$2.20
52-Week Price Range
$7.95
$4.23
47.99%
Downside
87.94%
Upside

TriSalus Life Sciences Inc. share price movements today

Previous Close: $4.20
Open: $4.12
Volume: 202.2K
Day's Low - High: $4.12 - $4.37
52 Week Low - High: $2.20 - $7.95

TriSalus Life Sciences Inc. Historical Returns

1 Month Return: + 28.83 %
3 Month Return: + 7.14 %
1 Year Return: -20.6 %
3 Year Return: 0 %
5 Year Return: 0 %

TriSalus Life Sciences Inc. Stock Fundamentals & Key Indicators

Check TriSalus Life Sciences Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$250.6M

EPS (TTM)

-0.45

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-27.4M

Revenue (TTM)

44.9M

Profit Margin

-60.85%

Return On Equity TTM

-496.21%

TriSalus Life Sciences Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of TriSalus Life Sciences Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
TriSalus Life Sciences Inc.	BUY	$250.6M	NA	NA	-60.85%	NA
Stryker Corporation	BUY	$118.0B	16.01%	35.58	13.21%	1.1400000000000001%
Edwards Lifesciences Corp	BUY	$50.3B	-18.02%	47.22	17.39%	NA
Medtronic plc	BUY	$101.6B	-36.83%	21.27	13.20%	3.63%
Boston Scientific Corp.	BUY	$67.3B	1.23%	18.95	17.29%	NA

See all

Stock Returns calculator for TriSalus Life Sciences Inc. Stock including INR - Dollar returns

The TriSalus Life Sciences Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

TriSalus Life Sciences Inc. investment value today

Current value as on today

₹87,494

Returns

-₹12,506

(-12.51%)

Returns from TriSalus Life Sciences Inc. Stock

-₹20,038 (-20.04%)

Dollar Impact

₹7,532 (+7.53%)

Analyst Recommendation on TriSalus Life Sciences Inc. Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for TriSalus Life Sciences Inc.. Average target price of $8.8

TriSalus Life Sciences Inc. Share Price Target

Get share price movements and forecasts by analysts on TriSalus Life Sciences Inc..

What analysts predicted

51.93%UPSIDE

Target Price

$8.8

Current Price

$4.23

Analyzed by

7 Analysts

Target

$8.80

TriSalus Life Sciences Inc. target price $8.8, a slight upside of 51.93% compared to current price of $4.23. According to 7 analysts rating.

Indian Investors' Interest in TriSalus Life Sciences Inc. Stock

Search interest for TriSalus Life Sciences Inc. Stock has decreased by -70% in the last 30 days, reflecting a downward trend in search activity.

Time period: May 24, 2026 to June 23, 2026

Change:-70% versus previous 30 day period

TriSalus Life Sciences Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	5	6	7	7	8	9	11	11	13	8
Gross Profit	5	5	6	6	7	7	9	9	11	7
Operating Income	-14	-11	-8	-8	-7	-7	-7	-9	-3	-8
EBITDA	-35	-13	-3	-1	-	-8	-6	-9	-8	3
Interest Expense	0	0	0	1	1	1	1	1	1	1
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-35	-13	-4	-2	-10	-10	-8	-10	-9	1
Income Tax Expense	0	0	0	0	-	0	0	0	0	0
Net Income	-35	-13	-4	-2	-10	-10	-8	-10	-9	1
Net Profit Margin	-620.68%	-204.72%	-58.83%	-32.64%	-122.36%	-113.18%	-73.91%	-93.47%	-73.86%	17.29%

TriSalus Life Sciences Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	8	12	18	29	45
Gross Profit	7	10	15	25	38
Operating Income	-24	-36	-54	-36	-26
EBITDA	-26	-46	-58	-32	-33
Interest Expense	1	0	0	3	5
Depreciation	0	0	0	0	0
Income Before Tax	-28	-47	-59	-30	-39
Income Tax Expense	0	0	0	0	0
Net Income	-28	-47	-59	-33	-39
Net Profit Margin	-343.35%	-380.60%	-320.69%	-112.92%	-86.88%

TriSalus Life Sciences Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-13	-4	-2	-10	-10	-8	-10	-9	1
Operating Cash Flow	-10	-13	-10	-5	-4	-7	-3	-2	-6
Investing Cash Flow	0	0	0	-	0	0	0	0	0
Financing Cash Flow	3	25	5	2	9	20	0	0	42
Change in Cash	-7	12	-5	-2	4	13	-3	-2	36

TriSalus Life Sciences Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-28	-47	-59	-30	-39
Operating Cash Flow	-22	-32	-50	-40	-18
Investing Cash Flow	-2	-1	-1	0	0
Financing Cash Flow	50	13	54	37	30
Change in Cash	25	-20	2	-3	11

Global Institutional Holdings in TriSalus Life Sciences Inc.

Funds	Holdings
Awm Investment Company Inc	3.39%
BlackRock Inc	2.44%
Thompson, Siegel & Walmsley LLC	0.95%
Northern Trust Corp	0.36%
Vanguard Fiduciary Trust Co	0.36%

See all

Insights on TriSalus Life Sciences Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -10.81M → 1.53M (in $), with an average increase of 372.3% per quarter
POSITIVE IMPACT
Price Rise
In the last 1 month, TLSI stock has moved up by 28.8%
NO EFFECT
Against Peers
In the last 3 years, TriSalus Life Sciences, Inc. Common Stock has experienced a drawdown of -59.9%, however Stryker Corporation resisted the overall trend and outperformed by 55.0%
NO EFFECT
Against Peers
In the last 1 year, Edwards Lifesciences Corp has given 14.0% return, outperforming this stock by 34.6%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 13.20M → 8.89M (in $), with an average decrease of 32.6% per quarter

About TriSalus Life Sciences Inc.

TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States. It offers Pressure-Enabled Drug Delivery (PEDD) infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial for treating locally advanced pancreatic cancer. The company is also developing nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and pancreatic cancer. It serves interventional radiologists, IR technicians, medical oncologists, nursing support, and value analysis committee staff. The company was founded in 2009 and is headquartered in Westminster, Colorado.

Organisation	TriSalus Life Sciences Inc.
Headquarters	6272 West 91st Avenue, Westminster, CO, United States, 80031
Industry	Medical Devices
CEO	Ms. Mary T. Szela B.S.N., M.B.A.
E-voting on shares	Click here to vote

Key Management of TriSalus Life Sciences Inc.

Name	Title
Mr. David B. Patience	Chief Financial Officer
Dr. Richard B. Marshak M.B.A., VMD	Chief Commercial Officer
Andrea Marasso	Vice President of Marketing
Ms. Jennifer L. Stevens J.D.	Chief Regulatory, Quality and Therapeutics Officer
Dr. Bryan F. Cox Ph.D.	Chief of Research
Dr. Richard Marshall M.D.	Medical Director
Ms. Mary T. Szela B.S.N., M.B.A.	CEO, President & Director

FAQs

What is TriSalus Life Sciences Inc. share price today?

TriSalus Life Sciences Inc. share price today is $4.23 as on June 23, 2026 at 10:42 pm IST. TriSalus Life Sciences Inc. share today touched a day high of $4.37 and a low of $4.12.

What is the 52 week high and 52 week low for TriSalus Life Sciences Inc. share?

TriSalus Life Sciences Inc. share touched a 52 week high of $7.95 on December 22, 2025 and a 52 week low of $2.2 on May 13, 2026. TriSalus Life Sciences Inc. stock price today i.e. June 23, 2026 at 10:42 pm IST is trending at $4.23,which is 46.79% down from its 52 week high and 92.27% up from its 52 week low.

What is TriSalus Life Sciences Inc.'s market capitalisation today?

TriSalus Life Sciences Inc. market capitalisation is $0.00T as on June 23, 2026 at 10:42 pm IST.

How to invest in TriSalus Life Sciences Inc. Stock (TLSI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for TriSalus Life Sciences Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in TriSalus Life Sciences Inc. Shares that will get you 0.3546 shares as per TriSalus Life Sciences Inc. share price of $4.23 per share as on June 23, 2026 at 10:42 pm IST.

What is the minimum amount required to buy TriSalus Life Sciences Inc. Stock (TLSI) from India?

Indian investors can start investing in TriSalus Life Sciences Inc. (TLSI) shares with as little as ₹94.735 or $1 (as of June 23, 2026 at 10:43 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹947.35 in TriSalus Life Sciences Inc. stock (as per the Rupee-Dollar exchange rate as on June 23, 2026 at 10:43 pm IST). Based on TriSalus Life Sciences Inc. share’s latest price of $4.23 as on June 23, 2026 at 10:42 pm IST, you will get 2.3641 shares of TriSalus Life Sciences Inc.. Learn more about fractional shares .